These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24036631)

  • 21. Cannabinoids and the skeleton: from marijuana to reversal of bone loss.
    Bab I; Zimmer A; Melamed E
    Ann Med; 2009; 41(8):560-7. PubMed ID: 19634029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formation.
    Sophocleous A; Landao-Bassonga E; Van't Hof RJ; Idris AI; Ralston SH
    Endocrinology; 2011 Jun; 152(6):2141-9. PubMed ID: 21447627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CB₂ receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
    Koppel J; Vingtdeux V; Marambaud P; d'Abramo C; Jimenez H; Stauber M; Friedman R; Davies P
    Mol Med; 2013 Nov; 19(1):357-64. PubMed ID: 24408112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial maladaptation to pressure overload in CB2 receptor-deficient mice.
    Duerr GD; Heinemann JC; Kley J; Eichhorn L; Frede S; Weisheit C; Wehner S; Bindila L; Lutz B; Zimmer A; Dewald O
    J Mol Cell Cardiol; 2019 Aug; 133():86-98. PubMed ID: 31181227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic characteristics of bone in carbonic anhydrase II-deficient mice.
    Margolis DS; Szivek JA; Lai LW; Lien YH
    Calcif Tissue Int; 2008 Jan; 82(1):66-76. PubMed ID: 18175028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age.
    Agudo J; Martin M; Roca C; Molas M; Bura AS; Zimmer A; Bosch F; Maldonado R
    Diabetologia; 2010 Dec; 53(12):2629-40. PubMed ID: 20835701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The P2Y13 receptor regulates phosphate metabolism and FGF-23 secretion with effects on skeletal development.
    Wang N; Robaye B; Gossiel F; Boeynaems JM; Gartland A
    FASEB J; 2014 May; 28(5):2249-59. PubMed ID: 24487286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skeletal development of mice lacking bone sialoprotein (BSP)--impairment of long bone growth and progressive establishment of high trabecular bone mass.
    Bouleftour W; Boudiffa M; Wade-Gueye NM; Bouët G; Cardelli M; Laroche N; Vanden-Bossche A; Thomas M; Bonnelye E; Aubin JE; Vico L; Lafage-Proust MH; Malaval L
    PLoS One; 2014; 9(5):e95144. PubMed ID: 24816232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VDR haploinsufficiency impacts body composition and skeletal acquisition in a gender-specific manner.
    de Paula FJ; Dick-de-Paula I; Bornstein S; Rostama B; Le P; Lotinun S; Baron R; Rosen CJ
    Calcif Tissue Int; 2011 Sep; 89(3):179-91. PubMed ID: 21637996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced humoral immunity in mice lacking CB1 and CB2 receptors (Cnr1-/-/Cnr2-/- mice) is not due to increased splenic noradrenergic neuronal activity.
    Simkins T; Crawford RB; Goudreau JL; Lookingland KJ; Kaplan BL
    J Neuroimmune Pharmacol; 2014 Sep; 9(4):544-57. PubMed ID: 24870806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
    Koppel J; Vingtdeux V; Marambaud P; d'Abramo C; Jimenez H; Stauber M; Friedman R; Davies P
    Mol Med; 2014 Mar; 20(1):29-36. PubMed ID: 24722782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoid receptor gene polymorphisms and bone mineral density in Korean postmenopausal women.
    Woo JH; Kim H; Kim JH; Kim JG
    Menopause; 2015 May; 22(5):512-9. PubMed ID: 25268406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of common variants in CNR2 gene for bone mineral density and osteoporosis susceptibility in postmenopausal women of Han Chinese.
    Zhang C; Ma J; Chen G; Fu D; Li L; Li M
    Osteoporos Int; 2015 Dec; 26(12):2803-10. PubMed ID: 26055357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo characterization of skeletal phenotype of genetically modified mice.
    Ke HZ
    J Bone Miner Metab; 2005; 23 Suppl():84-9. PubMed ID: 15984421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoid receptor 2 suppresses leukocyte inflammatory migration by modulating the JNK/c-Jun/Alox5 pathway.
    Liu YJ; Fan HB; Jin Y; Ren CG; Jia XE; Wang L; Chen Y; Dong M; Zhu KY; Dong ZW; Ye BX; Zhong Z; Deng M; Liu TX; Ren R
    J Biol Chem; 2013 May; 288(19):13551-62. PubMed ID: 23539630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The skeletal response to estrogen is impaired in female but not in male steroid receptor coactivator (SRC)-1 knock out mice.
    Mödder UI; Sanyal A; Xu J; O'Malley BW; Spelsberg TC; Khosla S
    Bone; 2008 Feb; 42(2):414-21. PubMed ID: 18055287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
    Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ
    Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cnr2 deficiency confers resistance to inflammation-induced preterm birth in mice.
    Sun X; Cappelletti M; Li Y; Karp CL; Divanovic S; Dey SK
    Endocrinology; 2014 Oct; 155(10):4006-14. PubMed ID: 25051450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanical and material properties of cortical and trabecular bone from cannabinoid receptor-1-null (Cnr1(-/-)) mice.
    Khalid AB; Goodyear SR; Ross RA; Aspden RM
    Med Eng Phys; 2016 Oct; 38(10):1044-54. PubMed ID: 27401043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregnane X receptor knockout mice display osteopenia with reduced bone formation and enhanced bone resorption.
    Azuma K; Casey SC; Ito M; Urano T; Horie K; Ouchi Y; Kirchner S; Blumberg B; Inoue S
    J Endocrinol; 2010 Dec; 207(3):257-63. PubMed ID: 20876238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.